Literature DB >> 10845111

Insights from mouse models into the molecular basis of neurodegeneration.

N Heintz1, H Y Zoghbi.   

Abstract

Thanks largely to cloning the genes for several neurodegenerative diseases over the past decade and the existence of mouse mutants, the molecular basis of neurodegeneration is finally beginning to yield some of its secrets. We discuss what has been learned about the pathogenesis of "triplet repeat" diseases through mouse models for spinocerebellar ataxia types 1 and 3 and Huntington disease, including the roles of nuclear aggregates and protein cleavage. We also discuss the neurologic phenotypes that arise from mutations in neurotransmitter receptors (lurcher mice) and ion channels (weaver, leaner, and tottering mice), drawing parallels between ischemic cell death and the neurodegeneration that occurs in the lurcher mouse. Finally, we discuss common mechanisms of cell death and lessons learned from these mouse models that might have broader relevance to other neurologic disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845111     DOI: 10.1146/annurev.physiol.62.1.779

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  21 in total

1.  Neurodegeneration in Lurcher mice occurs via multiple cell death pathways.

Authors:  M L Doughty; P L De Jager; S J Korsmeyer; N Heintz
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 2.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  Genetic control of the mouse cerebellum: identification of quantitative trait loci modulating size and architecture.

Authors:  D C Airey; L Lu; R W Williams
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.

Authors:  Michael Chiorazzi; Lixin Rui; Yandan Yang; Michele Ceribelli; Nima Tishbi; Carine W Maurer; Stella M Ranuncolo; Hong Zhao; Weihong Xu; Wing-Chung C Chan; Elaine S Jaffe; Randy D Gascoyne; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Shai Shaham; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

5.  An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity.

Authors:  K K Tai; S E Blondelle; J M Ostresh; R A Houghten; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene.

Authors:  Y Wang; D Huso; H Cahill; D Ryugo; J Nathans
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

7.  Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.

Authors:  Vera I Hashem; Malgorzata J Pytlos; Elzbieta A Klysik; Kuniko Tsuji; Mehrdad Khajavi; Merhdad Khajav; Tetsuo Ashizawa; Richard R Sinden
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

8.  Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila.

Authors:  Michael J Palladino; Tricia J Hadley; Barry Ganetzky
Journal:  Genetics       Date:  2002-07       Impact factor: 4.562

9.  Mediation of Af4 protein function in the cerebellum by Siah proteins.

Authors:  Peter L Oliver; Emmanuelle Bitoun; Joanne Clark; Emma L Jones; Kay E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-30       Impact factor: 11.205

10.  Abnormal cerebellar cytoarchitecture and impaired inhibitory signaling in adult mice lacking TR4 orphan nuclear receptor.

Authors:  Yei-Tsung Chen; Loretta L Collins; Hideo Uno; Samuel M Chou; Charles K Meshul; Shu-Shi Chang; Chawnshang Chang
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.